Gaithersburg-based molecular diagnostics company OpGen Inc. filed Tuesday to go public in hopes of raising as much as $37.4 million.
In its initial regulatory filing with the Securities and Exchange Commission, the company said it would trade on the Nasdaq under the ticker symbol OPGN. It has yet to set a price for the stock or date for the initial public offering, which New York-based Maxim Group LLC will manage.